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Abstract Although personalized medicine appears to be 
a truism, medical doctors are still generally trained in an 
old-fashioned manner with a focus on reactive treatment. 
The aim of this paper is to emphasize the evolution of life 
sciences into a more predictive science, where the devel-
opment of quantitative models is starting to take place. 
Personalized medicine is a consequence of such paradigm 
shift. To keep up with the change, the various actors within 
the health system must be trained in a completely differ-
ent manner, focusing on the ability to work as part of a 
multidisciplinary team that includes medical doctors, nurs-
es, engineers in medical imaging, and others who collect 
information from patients. In addition, these teams should 
include modelers that are able to integrate the flood of 
data into predictive and quantitative models. The chal-
lenge of implementing new training methods in line with 
the shift is a major bottleneck to the emergence and suc-
cess of personalized medicine in our societies.
Medicine has always been personal since it involves pri-
marily the interaction between a patient and his family 
doctor. However, the patient was not, and still is not, nec-
essarily at the center of the doctor’s thinking. The observ-
ables are the symptoms seen by the physician or felt by the 
patient. The doctor’s mission is to remove or reduce them 
by means of adequate therapies. Faced with a symptom 
or set of symptoms that indicate a particular disease, the 
physician makes the choice of therapy without regard to 
the patient’s individual characteristics. In the existing para-
digm, for a given disease the treatment is generally uni-
versal.
The study of the patient as a living system and the diseas-
es that can be linked to disturbances of this system has 
been carried out using a reductionist approach that, 
based on the current status of life sciences, is still 
limited to a descriptive phase. Life sciences are thus a do-
main describing the living organisms in which the descrip-
tive results are classified and structured but not yet used to 
build quantitative and predictive models (Figure 1).
This has several consequences:
1) A patient is considered to be a black box that can be 
observed in order to detect macroscopic observables and 
deviations from average behavior,
2) A patient is considered at different levels of complexity 
(or simplicity in reality) such as proteins, cell types, organs, 
organisms, without considering these elements in their 
globality. This leads to the impossibility of having a system-
ic view, and consequently the inability to either model the 
patient to understand the emergence of symptoms or to 
predict the effects of a treatment on a given patient.
3) A patient is observed for macroscopic parameters (tem-
perature, pressure, macroscopic images, etc) or by ques-
tioning him about how he feels. This circumstance is due 
to the lack of technologies to observe a healthy human or 
a patient comprehensively and at different levels of com-
plexity.
Figure 1. Medical doctor is linking symptoms to prescription.
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4) A future medical doctor is taught by observing his mas-
ters and accumulating a database of observations. He im-
proves his medical cognition from experience.
Biology is experiencing a transition from a descriptive sci-
ence to a predictive science. It is the evolution of -omics 
technologies that is enabling this development and ac-
companying its progression. In this context, biology and 
medicine are becoming systemic. We can, and must, con-
sider the healthy and the sick person as a biological sys-
tem that is apprehended in its totality and at all its levels 
of complexity.
This is a paradigm shift that leads us to consider:
1) The patient as an entity resulting from the integration 
of elements from the ecosystem (viral attack, xenobiotics, 
etc), genetic characteristics (to allow stratification of the 
patient population by attempting to create homogeneous 
groups thus facilitating stratified medicine), and individ-
ual elements (for customizing the approach to treatment 
which results in truly personalized medicine)
2) A physician to be a member of a multidisciplinary group 
of health care stakeholders with the aim of modeling the 
act of care to make it predictive for a particular patient 
(Figure 2).
This modeling, which should be deliberately very simple, 
will be composed of at least three steps that are described 
below in the context of a generic biological system:
1) A collecting data step where these data are heteroge-
neous, of variable quality and compose the patient’s clinical 
record that in the best scenario should be computerized.
2) A second step where the interactions between system 
elements are described, compared to, and complement-
ed by, existing data in public databanks or references. One 
goal is to have a comprehensive view of existing or pre-
dicted interactions and to then analyze the topology of the 
resulting interaction graph.
3) The third step is to quantify the flow of matter, energy 
or information between the nodes of this (these) interac-
tion network(s).
These three steps can approach a partial or complete pa-
tient model that can be used to make rational therapeu-
tic decisions assisted by computer technologies (or, for the 
health industry, to address computer assisted rational de-
sign of new therapies) (1) (Figure 3).
Training of physicians who enter the era of personalized 
medicine is of utmost importance and the traditional aca-
demic setting has to be adapted in the light of the new 
paradigm. Training courses have to be rethought in a new 
pedagogical space and include at least:
1) A pedestal of cognition that, in addition to medical 
knowledge, takes into account training in database build-
ing, graph theory, and signal theory,
2) Development of skills to allow physicians to work as a fully 
integrated member of a team as well as manage a project,
3) Immersion of groups of students into real projects in or-
der to develop creativity and innovation (Figure 4).
Ideally, the curriculum of a medical doctor involved in 
personalized medicine, will be also customized for 
Figure 2. The patient is at the center of the health system.
Figure 3. The three steps to build a qualitative and predictive 
model.
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each student. That will necessitate a modification of the 
professor’s skills. The teacher must not only be a lecturer 
but also a coach. Indeed, a specific individual must devel-
op specific skills to integrate with a multidisciplinary team. 
Therefore, although somewhat counterintuitive, acquiring 
a team spirit for a physician in training will require a per-
sonalized curriculum.
Another challenge for the community of professors is to 
encourage creativity and innovation, namely to find new 
methods to train modelers of biology and to induce an ap-
preciation and appetite for modeling on the part of biolo-
gists. Some pilot experiments have been reported in a re-
cent article in Science (2).
The use of serious games may also be a necessity to fa-
cilitate the building of a common language between the 
variety of disciplines that need to interact for the sake of 
personalized medicine (3,4).
In conclusion, three main challenges can be envisioned::
1) In research: when personalized medicine approaches re-
quire drugs that act on the cellular interaction network of 
a given individual, and not on a specific component of this 
network, we must be able to build models that allow us 
to predict the action of the drug on a specific patient or a 
group of patients,
2) With the society and the patient associations: the target-
ed therapies and the therapeutic innovations have to be 
discussed in order to anticipate the necessary regulations 
for a safe usage of those innovative therapies, and for their 
access to the whole population,
3) In education: the training of medical doctors but also 
the appreciation of new actors in the health organization 
that together need to change the training principles that 
have been applied since the time of the Ancient Greeks 
and the Egyptians.
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